Different LPARs mediate radio-resistance in different cancer cells, and LPAR1 is a pronounced receptor to mediate radio-resistance because of its ability to stabilize Nrf2 via PI3K signaling [86,88,98]. Here, NFE2L2 is linked to cancer.